Welcome to our new Executives-in-Residence!
View this email in your browser
October 6, 2015

Welcome to our new Executives-in-Residence!

We are very excited about our six new CTV Executives-in-Residence (XIRs), who are available to any Columbia researcher, student, or staff for advice on how to best commercialize their technologies. This class of XIRs has expertise spanning a range of fields including software, life sciences, drug discovery, engineering, angel investing, intellectual property licensing and more, with experience at various startups as well as Kleiner Perkins, Bell Labs, Intel, Roche, HP, Genentech, and other publicly traded companies. You can also see their full bios here, but in brief:

  • David Murphy, CTV’s “Founding XIR,” returns to Columbia! David has held senior executive roles at HP, Mercury Interactive, Asera Systems, Tivoli/IBM and McKinsey over a 30 year+ technology industry career; has been an EIR at Garnett-Helfrich and a member of numerous start-up Boards; most recently was President/COO of cybersecurity company Blue Coat Systems which was sold to Bain Capital earlier this year;
  • Gordon Stewart, most recently Director of Global IP Strategy and Portfolio Management at Bell-Labs / Alcatel Lucent, brings 20 years of experience in IP licensing, business development, and patent portfolio management, in both corporate and university settings and in both the physical and life sciences;
  • Nicholas Wood, one of Intel’s early employees, has been a founder and advisor to many high-tech startups and is currently investing in clean energy, water, instrumentation and medical device markets;
  • Diego Carranza, a healthcare executive from Roche/Genentech and Forest Laboratories, brings diverse U.S. and international expertise in both pharmaceutical and consumer health businesses across disease areas and markets;
  • Barry Kappel was most recently part of the senior team at biotech startup ContraFect, focused on therapeutic protein and antibody products for infectious diseases, which went public on the NASDAQ;
  • Natalie Tucker is Director of Clinical and Medical Strategies at MELA Sciences, Inc., a medical device company focused on providing diagnostic aids for the early detection of melanoma.

Our XIRs offer an invaluable resource to the Columbia community by helping to accelerate the path of many promising technologies toward market success. For those in the Columbia community, speak with your CTV licensing officer or email techventures@columbia.edu to arrange a meeting with any of our XIRs.


Orin Herskowitz
Executive Director, CTV
VP for Intellectual Property & Technology Transfer

Professor Kartik Chandran Wins MacArthur “Genius” Grant

Diagnostics Breakthrough Brings Viral Sequencing to Doctors’ Toolkit

VIDEO: Advice for entrepreneurs on startup IP strategy

VIDEO: Lessons learned from working with patent attorneys


Patents 101

October 7 | CUMC | Learn the basics of IP, patenting, and how to protect your innovations before disclosure at this session, focused on the life sciences. Learn more.


Lean Launchpad Info Session

October 8 | Morningside | The Lean Launchpad provides real world, hands-on training for those interested in starting a company. Learn more at this info session.


ELabNYC Info Session

October 8 | Microsoft | ELabNYC offers entrepreneurs the chance to evolve their technology into a viable company. Find out more at this info session.


Columbia-Coulter Translational Research Partnership Info Sessions

October 13 & 15 | Morningside & CUMC  | Learn about the Columbia-Coulter program, a partnership that provides funding and mentorship to develop emerging biomedical and engineering innovations. 


Mock Patent Examination

October 15 | Morningside | Find out how your patent app might hold up under prosecution as Columbia's Chief Patent Counsel leads this interactive session. 


IP Primer and Considerations for Inventors, Entrepreneurs, and Startups

October 15 | Cornell Tech | Join the USPTO for a discussion about what all inventors, small businesses, and start-ups should know about intellectual property.


Annual Fall Venture Fair

October 27 | AppNexus | The Fall Venture Fair offers students the chance to present ideas and get feedback from successful entrepreneurs. Learn more.


IE@Columbia Info Session

October 28 | Morningside | Tap into the knowledge and network of Columbia by joining a team to develop an entrepreneurial venture with Innovation and Entrepreneurship @ Columbia.


NYC Life Science Innovation Showcase

November 4 | Alexandria Center | Hear pitches from faculty innovators and startups from 13 of NYC's research institutions, including Columbia, and network at the NYC Life Science Innovation Showcase.


Apply for NYC Media Lab's Combine Program

December 1 | Apply for the Combine, a new program designed to match media technologies emerging from the university with training and resources to commercialize them.

Discover #ColumbiaInnovation

Columbia University has over 1200 active patent assets available for licensing.
See some of our latest opportunities below, or click here to discover more
Modified protein for alleviating iron accumulation due to chronic iron overload | Learn more

Skeletal stem cell for the regeneration of cartilage and bone and treatment of osteoarthritis: the osteochondroreticular stem cell | Learn more

Detection of single proteins in a multiplex system using tags and nanopores | Learn more

Lab-on-chip for high-throughput evaluation of radiation dosage | Learn more

CAREX: A lightweight exoskeleton for stroke rehabilitation of the arm | Learn more

Want more? Click here for a full list of events and opportunities.

Copyright © 2015 Columbia Technology Ventures, All rights reserved.

Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list